Tag

Evidently, to date, over 170,000 breast cancer patients have changed their treatment decision based on the Oncotype DX test, with a majority adopting hormonal therapy alone.

Researchers have found that many women diagnosed with early-stage breast cancer may be able to forgo adding chemotherapy to a regimen of hormone-blocking meds, without hurting their chances of beating the dreaded disease thanks to gene testing.